Company Filing History:
Years Active: 2001-2004
Title: René Laversanne: Innovator in Pharmaceutical Compositions
Introduction
René Laversanne is a notable inventor based in Pessac, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral administration. With a total of 3 patents, Laversanne's work has the potential to impact various therapeutic areas.
Latest Patents
Laversanne's latest patents include groundbreaking methods for pharmaceutical compositions. One of his notable inventions involves a method for oral administration of an active principle. This method incorporates the active principle in multilamellar vesicles, which have a diameter ranging from 0.1 to 25 µm. The vesicles feature a lamellar liquid-crystal internal structure, consisting of concentric bilayers based on amphiphilic agents, alternating with layers of water or polar liquid. This innovative approach enhances the oral administration of pharmaceutical compositions.
Another significant patent focuses on compositions containing at least one nucleic acid. This composition includes a plurality of multicellular vesicles, with at least one nucleic acid found within the multilamellar vesicles. Each vesicle is formed of concentric lamellar bi-layers, which extend from the center to the periphery and include surfactant agents. These compositions hold promise for applications in pharmaceutics, particularly in gene therapy and transfection.
Career Highlights
Throughout his career, Laversanne has worked with various companies, including Capsulis and Capsules. His expertise in pharmaceutical compositions has allowed him to contribute to advancements in drug delivery systems and therapeutic applications.
Collaborations
Laversanne has collaborated with notable professionals in his field, including Joëlle Amedee and Didier Roux. These collaborations have further enriched his research and development efforts.
Conclusion
René Laversanne is a distinguished inventor whose work in pharmaceutical compositions has the potential to revolutionize oral drug delivery and gene therapy. His innovative patents and collaborations highlight his commitment to advancing the field of pharmaceuticals.